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Secondhand smoke (SHS) may act as a smoking cue and prime dose of nicotine by activating 
acetylcholine receptors in brains to trigger smoking (1). SHS exposure at home and having a 
smoking spouse or peers predicted lower likelihood of smoking cessation in cancer patients 
(2). Similar cross-sectional findings were found in cardiac patients (3). This study 
prospectively investigated the roles of SHS exposure at home and outside home on smoking 
cessation among cardiac out-patients in Hong Kong (19.1% men and 3.1% women smoked 
daily in 2012). 
 
We used data from a randomized controlled trial (RCT), which found no difference on 
smoking cessation between stage-matched intervention and control groups (4). A total of 
1495 (80.4%) adult smokers attending the cardiac out-patient clinics in major hospitals in 
Hong Kong were interviewed and followed at 12-month. SHS exposure at home was reported 
at baseline and categorized as none, ≤1 hour/day and >1 hour/day. The number of smoking 
family members and exposure to SHS outside home were categorized as none and any. 
Smoking cessation was defined as self-reported abstinence in the past 30 days at 12-month 
follow-up. Socio-demographic characteristics, alcohol drinking, smoking quantity and 
duration, long-term medication use and cardiac surgery received were recorded and treated as 
potential confounders. Associations of having smoking family member(s), SHS exposure at 
home and SHS exposure outside home with smoking cessation were analyzed adjusting for 
intervention allocation (Model 1), demographic characteristics and smoking behaviors 
(Model 2) and clinical variables (Model 3), using logistic regressions to yield adjusted odds 
ratios (AORs). 
 
The subjects (91.2% male, mean age 59 ±13.7) smoked for an average of 39.3 (±15.1) years 
and consumed cigarettes for 41 (±27.4) pack-years. Having smoking family member(s) 
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(24.3%) was associated with a lower AOR (95% CI) of 0.64 (0.49-0.83) for smoking 
cessation with the same effect size after adjusting for various potential confounders in 
different models (Table 1). Any SHS exposure at home (20.2%) was associated with an AOR 
(95% CI) of 0.65 (0.48-0.89) for smoking cessation, and increasing duration of SHS exposure 
at home was associated with decreasing odds of smoking cessation (P for trend <0.001). SHS 
exposure outside home (89.6%) was not significantly associated with smoking cessation. 
Repeated analyses using 7-day abstinence as smoking cessation yielded similar results (tables 
not shown).   
 
We found a prospective, dose-response and robust association between SHS exposure at 
home and lower likelihood of smoking cessation in cardiac out-patients. The magnitude of 
the association was in line with our studies on adolescents, but is smaller than studies on 
patients with cancer (AOR 0.19-0.25) and coronary heart disease (AOR 0.26). SHS exposure 
outside home in our subjects was likely and mostly from indoor workplaces, restaurants and 
streets where the exposure should be less intense than at home. This may explain the 
non-significant association between SHS exposure outside home and smoking cessation. 
 
Smoking cessation is one of the most effective strategies for primary and secondary 
prevention of cardiovascular disease (CVD) but received far less attention than other CVD 
risk factors such as hypertension, hyperlipidemia and diabetes (5). Cardiologists play an 
important role in assisting smokers to quit particularly at teachable moments of CVD 
diagnosis and hospitalization. Current practice guidelines for smoking cessation based on the 
evidence from pharmacological and behavioral trials achieved lower than 50% abstinence at 
12-month follow-up. In addition to standard smoking cessation practices, cardiologists should 
assess SHS exposure in smokers and advise smokers to avoid being exposed to SHS and 
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smoking cues. Including family members in smoking cessation counseling may be warranted 
particularly for CVD patients who usually require lifestyle and behavioral modifications 
using a family-centered approach. Future interventions including counseling on SHS 
reduction may produce extra beneficial effects on smoking cessation in cardiac patients in 
addition to the beneficial effects of avoiding SHS on cardiovascular function in smokers.     
  
All information are self-reported and subjected to reporting bias. Using biological markers of 
SHS exposure could not distinguish places of exposure which were differentially associated 
with smoking cessation. The generalizability of this study might be limited as it was 
originally designed as a trial and adopted a non-random sampling method, although the 
subjects were screened based on a large pool of patients (N=60588). 
 
We found SHS exposure at home was associated with lower likelihood of smoking cessation 
among cardiac out-patients. Interventions to reduce SHS exposure may increase quitting 
among cardiac patients.  
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Table 1 Associations of SHS exposure and smoking cessation at 12-month follow up 
Family smoking and SHS 
exposure 
Model 1 (N=1495) Model 2 (N=1469) Model 3 (N=1359) 
AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Smoking family member(s)    
 None 1 1 1 
 Any 0.64 (0.49-0.83)*** 0.62 (0.47-0.82)*** 0.64 (0.48-0.86)** 
SHS exposure at home  
 None 1 1 1 
 ≤1 hour/day 0.74 (0.54-0.99)* 0.73 (0.54-0.99)* 0.73 (0.53-1.00) 
>1 hour/day 0.24 (0.08-0.67)** 0.26 (0.09-0.74)* 0.14(0.03-0.61)** 
 P for trend <0.001 <0.01 <0.001 
 Any 0.66 (0.50-0.88)** 0.67 (0.49-0.90)** 0.65 (0.48-0.89)** 
Family smoking and home SHS    
None smoked without SHS 1 1 1 
Any smoked without SHS 0.88 (0.55-1.4) 0.81 (0.50-1.30) 0.89 (0.53-1.47) 
Any smoked with SHS 0.56 (0.4-0.77)*** 0.55 (0.39-0.77)** 0.57 (0.40-0.81)** 
P for trend <0.001 <0.001 <0.01 
SHS exposure outside home 
 None 1 1 1 
 Any 0.87 (0.61-1.24) 0.88 (0.61-1.27) 0.85 (0.58-1.24) 
Mode 1 adjusted for group assignment (intervention or control). Model 2 adjusted for model 1 
variable, baseline sex, age, self-rated health and lifetime cigarette consumption. Model 3 adjusted 
for model 2 variables, baseline duration of heart disease, long term medication and ever had heart 
surgery. AOR = adjusted odds ratio. 
*P<0.05, **P<0.01 
 
